Assessment of performance measures for patients with the myelodysplastic syndrome (MDS) in the United States.
2010
6002 Background: Although baseline bone marrow examination and assessment of iron stores before initiating an erythropoiesis-stimulating agent (ESA) are nationally endorsed performance measures for...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI